Itraconazole pharmacokinetics in patients with renal dysfunction.
AUTOR(ES)
Boelaert, J
RESUMO
The single-dose pharmacokinetics of 200 mg of oral itraconazole were studied in seven uremic patients, seven patients treated by hemodialysis, and five patients treated by continuous ambulatory peritoneal dialysis. Plasma concentration-versus-time profiles showed wide intersubject variation. This study could not demonstrate any significant effect of renal dysfunction and hemodialysis or continuous ambulatory peritoneal dialysis treatment upon the pharmacokinetics of itraconazole, and firm conclusions concerning dosing in such patients should await confirmation of our data in a larger patient population.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=175928Documentos Relacionados
- Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
- Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.
- Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.
- Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
- Colchicine myoneuropathy and renal dysfunction.